NHS launches spring COVID-19 booster campaign
9th April 2025 Uncategorised 0An estimated 7.5 million people will be invited to receive the booster More: NHS launches spring COVID-19 booster campaign Source: News
read more
An estimated 7.5 million people will be invited to receive the booster More: NHS launches spring COVID-19 booster campaign Source: News
read more
AI-powered SkyMind is designed to improve efficiency, compliance and decision-making More: SkyCell and Microsoft partner to improve pharma supply chains Source: News
read moreA New York City federal court has dismissed a proposed class action lawsuit against Bristol Myers Squibb that accused the drugmaker of deploying anticompetitive tactics to protect the market exclusivity of key multiple myeloma drug Pomalyst. More: BMS prevails in
read moreWhile the omission of pharmaceuticals from President Donald Trump’s much-anticipated reciprocal tariffs gave the industry a momentary reprieve, renewed threats of drug duties—which have pressured scores of health stocks—suggest any relief is likely short-lived. More: Pharma stocks slip as Trump
read moreContract manufacturer PharmaLogic is picking up a majority stake in Norway’s Agilera Pharma. The move forms part of the Florida-based CDMO’s plan to position itself as a global leader in radiopharmaceutical therapies. More: CDMO PharmaLogic takes majority stake in Norway's
read morePeter Marks, M.D., Ph.D., the former director of the Center for Biologics Evaluation and Research, told the Associated Press that he blocked HHS secretary Robert F. Kennedy, Jr. from securing full access to the Vaccine Adverse Events Reports System in
read more© 1994 - 2026 B.M. Pharmaceuticals